Press Kit

Techulon’s Solution: Rapidly Adaptable Nano Therapeutic (RANT) Platform • Highly efficient drug discovery and development process • Techulon is using this process to develop a new class of novel antibiotics • Techulon has pipeline drugs addressing pathogens on the World Health Organizations "Critical" threat pathogens • Efficacy of lead candidates are proving to be as efficacious as current treatments of choice • Have a lower toxicity profile than current treatments of choice • Have less impact on off-target, beneficial bacteria resulting in better stewardship, and, better clinical care • Very importantly, targeted pathogens have been unable to develop resistance to Techulon's drugs in multiple resistance studies